Health Care Bellwether J&J Misses Sales Views, But Profit Beats

Early Tuesday, Johnson & Johnson (JNJ) reported adjusted earnings of $2.71 per share on $21.38 billion in first-quarter sales. Johnson & Johnson stock dipped a fraction.


Analysts polled by FactSet expected the pharma and medtech behemoth to earn $2.64 per share and report $21.39 billion in sales.

During the year-earlier period, Johnson & Johnson earned $2.41 a share on $20.89 billion in sales.

For the year, J&J guided to adjusted earnings of $10.57 to $10.72 per share and $88 billion to $88.4 billion in sales. Analysts called for earnings of $10.66 a share and $88.42 billion in sales.

In premarket trading on today’s stock market, Johnson & Johnson stock fell 0.7% to 146.50.

More to follow.

Follow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.


Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit

Join IBD Live For Stock Ideas Each Morning Before The Open

Want More IBD Insights? Subscribe To Our Investing Podcast!

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

Source link